Page 10 - Imclone Systems News Today : Breaking News, Live Updates & Top Stories | Vimarsana

/PRNewswire/ -- ONA Therapeutics ("ONA"), which is focused on the discovery and development of therapeutic biologics targeting lipid metabolism in order to...

The Manual of Patent Practice (MOPP) explains the Intellectual Property Office's practice under the Patents Act 1977.

Judge who presided over Michael Cohen case dies at age 68 By LARRY NEUMEISTER Associated Press July 6, 2021 — 4:02pm Text size Copy shortlink: NEW YORK — Judge William H. Pauley III, who presided over the criminal case against ex-President Donald Trump's former personal lawyer during a tenure on the federal be...

/PRNewswire/ -- MorphImmune, Inc., a private platform company that is advancing a highly specific targeting technology that uses a ligand-linked payload to...

A Story of Investing in Biotech — the One Where Martha Stewart Goes to Jail Posted May 18, 2021 ImClone Systems was a market darling back in the day. The stock price went from single digits to $170 a share in about a year. ImClone was a biotech company that developed a drug called Erbitux.  Today, Erbitux is a cancer medicine that interferes with the spread of cancer cells in the body. The drug is used in combination with other drugs to treat colon and rectal cancer as well as head and neck cancer. It is useful but not a cure-all, and it has competition in the marketplace.